Population
Patients with Brugada syndrome (BrS)
Design
Review
Key result
Recent advances in Brugada syndrome therapy highlight ICD as first-line treatment, with pharmacological approaches and radiofrequency ablation serving as important adjuncts.
Authors
Loading...
Supports ICD-first strategy in Brugada syndrome; leaves open efficacy of novel Ito blockers pending randomized trials.
This review summarizes current treatments for Brugada syndrome, emphasizing ICDs as first-line therapy and highlighting the need for novel cardio-selective Ito blockers.
Argenziano et al. (2018) conducted a review in Brugada syndrome. ICD, pharmacological therapy, and radiofrequency ablation was evaluated. Recent advances in Brugada syndrome therapy highlight ICD as first-line treatment, with pharmacological approaches and radiofrequency ablation serving as important adjuncts.